Assembly Biosciences Inc (ASMB)
14.70
+0.80
(+5.76%)
USD |
NASDAQ |
May 15, 15:53
Assembly Biosciences Price to Book Value: 2.486 for May 15, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 14, 2024 | 2.351 |
| May 13, 2024 | 2.264 |
| May 10, 2024 | 2.266 |
| May 09, 2024 | 2.200 |
| May 08, 2024 | 2.173 |
| May 07, 2024 | 2.134 |
| May 06, 2024 | 2.173 |
| May 03, 2024 | 2.224 |
| May 02, 2024 | 2.154 |
| May 01, 2024 | 2.232 |
| April 30, 2024 | 2.097 |
| April 29, 2024 | 2.170 |
| April 26, 2024 | 2.128 |
| April 25, 2024 | 2.247 |
| April 24, 2024 | 2.267 |
| April 23, 2024 | 2.232 |
| April 22, 2024 | 2.223 |
| April 19, 2024 | 2.255 |
| April 18, 2024 | 2.242 |
| April 17, 2024 | 2.173 |
| April 16, 2024 | 2.442 |
| April 15, 2024 | 2.511 |
| April 12, 2024 | 2.464 |
| April 11, 2024 | 2.533 |
| April 10, 2024 | 2.469 |
| Date | Value |
|---|---|
| April 09, 2024 | 2.498 |
| April 08, 2024 | 2.422 |
| April 05, 2024 | 2.316 |
| April 04, 2024 | 2.294 |
| April 03, 2024 | 2.319 |
| April 02, 2024 | 2.270 |
| April 01, 2024 | 2.170 |
| March 31, 2024 | |
| March 28, 2024 | 1.774 |
| March 27, 2024 | 1.785 |
| March 26, 2024 | 1.742 |
| March 25, 2024 | 1.761 |
| March 22, 2024 | 1.732 |
| March 21, 2024 | 1.628 |
| March 20, 2024 | 1.653 |
| March 19, 2024 | 1.578 |
| March 18, 2024 | 1.574 |
| March 15, 2024 | 1.624 |
| March 14, 2024 | 1.608 |
| March 13, 2024 | 1.686 |
| March 12, 2024 | 1.705 |
| March 11, 2024 | 1.788 |
| March 08, 2024 | 1.812 |
| March 07, 2024 | 1.773 |
| March 06, 2024 | 1.762 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4159
Minimum
Feb 23 2022
4.494
Maximum
Dec 24 2019
1.292
Average
0.8691
Median
Price to Book Value Benchmarks
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7122 |
| Theriva Biologics Inc | 0.2010 |
| Oragenics Inc | 4.693 |
Price to Book Value Related Metrics
| Price to Free Cash Flow | 2.608 |
| Price | 14.70 |
| Earnings Yield | -71.29% |
| Market Cap | 81.05M |